DONNINI, Claudia
 Distribuzione geografica
Continente #
NA - Nord America 3.627
EU - Europa 3.188
AS - Asia 1.262
AF - Africa 8
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 1
Totale 8.093
Nazione #
US - Stati Uniti d'America 3.557
CN - Cina 1.061
IE - Irlanda 730
SE - Svezia 620
FI - Finlandia 480
IT - Italia 466
UA - Ucraina 406
DE - Germania 269
TR - Turchia 120
GB - Regno Unito 106
CA - Canada 69
FR - Francia 36
SG - Singapore 34
BE - Belgio 26
IN - India 20
ES - Italia 14
NL - Olanda 12
HK - Hong Kong 10
IR - Iran 5
PK - Pakistan 5
RU - Federazione Russa 4
EG - Egitto 3
EU - Europa 3
KE - Kenya 3
NZ - Nuova Zelanda 3
CZ - Repubblica Ceca 2
EE - Estonia 2
HR - Croazia 2
LB - Libano 2
NO - Norvegia 2
PL - Polonia 2
PT - Portogallo 2
VN - Vietnam 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
AU - Australia 1
AZ - Azerbaigian 1
CO - Colombia 1
HU - Ungheria 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LY - Libia 1
MK - Macedonia 1
PA - Panama 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 8.093
Città #
Chandler 716
Dublin 700
Jacksonville 458
Ashburn 281
Beijing 262
Dearborn 262
Ann Arbor 218
Nanjing 168
Princeton 144
Parma 125
Izmir 117
San Mateo 116
Wilmington 87
New York 67
Jinan 65
Toronto 62
Shenyang 61
Boardman 56
Nanchang 54
Helsinki 53
Shanghai 47
Des Moines 44
Hebei 44
Kunming 44
Woodbridge 42
Tianjin 39
Hefei 37
Changsha 32
Bremen 29
Brussels 24
Jiaxing 24
Guangzhou 19
Salerno 19
Redmond 17
Falls Church 16
Zhengzhou 16
Hangzhou 15
Norwalk 15
Bologna 14
Houston 14
Seattle 14
Colchester 13
Rome 12
Taiyuan 12
Vicenza 12
Haikou 11
Los Angeles 10
Dosolo 9
Fremont 9
Fuzhou 9
Almería 8
Bari 8
Lanzhou 8
Pune 8
Washington 8
Auburn Hills 7
Gravina di Catania 7
Trezzano Sul Naviglio 7
Abbiategrasso 6
Atlanta 6
Borås 6
Brescia 6
Fairfield 6
Ottawa 6
Piacenza 6
Wenzhou 6
Chongqing 5
Edinburgh 5
Quzhou 5
Avola 4
Chengdu 4
Colere 4
Dronten 4
Grafing 4
London 4
Messina 4
Newcastle Upon Tyne 4
Ningbo 4
Oleggio 4
Padova 4
Perugia 4
Redwood City 4
Reggio Nell'emilia 4
Scafati 4
Shaoxing 4
Wuhan 4
Auckland 3
Cairo 3
Chicago 3
Düsseldorf 3
Este 3
Fontanellato 3
Frankfurt am Main 3
Jinhua 3
Madrid 3
Manchester 3
Milan 3
Modena 3
Peterborough 3
Rockville 3
Totale 4.968
Nome #
Genetic and Environmental Risk Factors for Cannabis Use: Preliminary Results for the Role of Parental Care Perception 114
Yeast as a model system to shed light on the role of the human disease protein Mpv17 109
DNA polymerase [gamma] and disease: what we have learned from yeast 105
Elongator-dependent modification of cytoplasmic tRNALysUUU is required for mitochondrial function under stress conditions 96
Yeast, worm, patient’s fibroblasts and zebrafish as models for drug repositioning of molecules targeting POLG-related diseases 89
IMP2, a nuclear gene controlling the mitochondrial dependence of galactose, maltose and raffinose utilization in Saccharomyces cerevisiae. 87
Adrenocorticotropic hormone and cortisol plasmalevels directly correlate with childhood neglect anddepression measures in addicted patients 86
Alcohol use disorders among adult children of alcoholics (ACOAs): Gene-environment resilience factors 86
Pathogenic variants in glutamyl-tRNAGlnamidotransferase subunits cause a lethal mitochondrial cardiomyopathy disorder 82
Mutations in AAC2, equivalent to human adPEO-associated ANT1 mutations, lead to defective oxidative phosphorylation in Saccharomyces cerevisiae and affect mitochondrial DNA stability 80
ALG/alg: a single gene controlling the utilization of lactate in the presence of antimycin in the yeast Saccharomyces cerevisiae. 8: 407-411. 80
Allelic association of a dopamine transporter gene polymorphism with antisocial behaviour in heroin-dependent patients 79
Adverse childhood experiences (ACEs), genetic polymorphisms and neurochemical correlates in experimentation with psychotropic drugs among adolescents 78
Genetic, physiological and molecular characterization of MPV17/SYM1 mutations in S. cerevisiae 78
Secretion of human serum albumin from Kluyveromyces lactis over-expressing KlPDI1 and KlERO1 genes 77
Mutations in AAC2, equivalent to human adPEO-associated ANT1 mutations, lead to defective oxidative phosphorylation in Saccharomyces cerevisiae and affect mitochondrial DNA stability 77
Yeast as a model of mitochondrial dysfunctions: neurodegenerative diseases and cancer. 76
Childhood neglect and parental care perception in cocaine addicts: Relation with psychiatric symptoms and biological correlates 75
Clinical Features, Molecular Heterogeneity, and Prognostic Implications in YARS2-Related Mitochondrial Myopathy 75
Pathological alleles of MPV17 modeled in the yeast Saccharomyces cerevisiae orthologous gene SYM1 reveal their inability to take part in a high molecular weight complex 75
A yeast-based repurposing approach revealed modulation of dNTP pool as a therapeutic target to treat mitochondrial DNA depletion syndromes 75
TRMT5 Mutations Cause a Defect in Post-transcriptional Modification of Mitochondrial tRNA Associated with Multiple Respiratory-Chain Deficiencies 74
Polymorphisms in DNA polymerase γ affect the mtDNA stability and the NRTI-induced mitochondrial toxicity in Saccharomyces cerevisiae 74
Analysis of rho mutability in Saccharomyces cerevisiae. I. Effects of mmc and pet-ts alleles 73
Costruzione di un mutante imp2 termosensibile di Saccharomyces cerevisiae 72
Catabolite repression by galactose in overexpressed GAL4 strains of Saccharomyces cerevisiae 72
Costruzione di un mutante imp2 termosensibile di Saccharomyces cerevisiae 71
A Novel Homozygous YARS2 Mutation in Two Italian Siblings and a Review of Literature 71
SYM1, the yeast ortholog of the MPV17 human disease gene, is required for TCA function, mtDNA stability and mitochondrial morphology in stress conditions 71
Allelism of IMP1 and GAL2 genes of Saccharomyces cerevisiae 71
Analysis of polymorphism in genes involved in serotonergic and dopaminergic transmission in male heroin-dependent subjects: behavioural and personality correlates 69
SYM1, the yeast ortholog of the MPV17 human disease gene, is required for TCA function, mtDNA stability and mitochondrial morphology in stress conditions 69
A homozygous mutation in LYRM7/MZM1L associated with early onset encephalopathy, lactic acidosis and severe reduction of mitochondrial complex III activity. 69
Sideroblastic anemia with myopathy secondary to novel, pathogenic missense variants in the YARS2 gene 69
Characterization of the Saccharomyces cerevisiae SYM1 gene, ortholog of the human desease gene MPV17 68
Elementi regolativi implicati nel processo di repressione /derepressione da glucosio in Kluyveromyces lactis: differenze rispetto a Saccharomyces cerevisiae 67
L'aumento del dosaggio del gene ero1 favorisce la secrezione di proteine ricombinanti in Kluyveromyces lactis 67
Germination conditions that require mitochondrial function in Saccharomyces cerevisiae: utilization of acetate and galactose 67
The identification of beneficial molecules for mitochondrial diseases: Saccharomyces cerevisiae as powerful model 67
Analysis of Monoamine Oxidase a (MAO-A) promoter polymorphism in male heroin dependent subjects: behavioral and personality correlates 66
Genetic improvement of the yeast Kluyveromyces lactis for biotechnological purposes 66
THE ROLE OF GLUCOSE AND AMINOACID STARVATION IN THE SENSITIVITY OF PROTEIN AND RNA SYNTHESIS TO CYCLOHEXIMIDE AND ERYTROMYCIN IN THE YEAST SACCHAROMYCES CEREVISIAE. 66
ANALYSIS OF RHO MUTABILITY IN SACCHAROMYCES CEREVISIAE. II. ROLE OF THE MITOCHONDRIAL PROTEIN SYNTHESIS. 66
VARS2 and TARS2 Mutations in Patients with Mitochondrial Encephalomyopathies 66
EFFECT OF CHLORAMPHENICOL, ANTIMYCIN A AND HYDROXAMATE ON THE MORPHOGENETIC DEVELOPMENT OF THE DIMORPHIC ASCOMYCETE ENDOMYCOPSIS CAPSULARIS. 65
In vivo differentiation with trichodermin,axenomycin,emetine,anisomycin and erythromycin of cytoplasmic and mitochondrial protein synthesis in the yeasts S.cerevisiae, K.lactis and E.capsularis 65
Association of the serotonin transporter promoter polymorphism with smoking behavior among adolescents 64
Compartmentalization in the control of RNA and protein synthesis during nutritional shift-down in the yeast Saccharomyces cerevisiae 64
Germination of Saccharomyces cerevisiae ascospores without trehalose mobilization as revealed by in vivo 13C nuclear magnetic resonance spectroscopy 64
Pathological Role of Mutations in Human MPV17: Saccharomyces cerevisiae as a Model System 64
Mitochondrial Aminoacyl-tRNA Synthetase: The Power Of Yeast In Modeling Human Pathological Mutations 64
MIG1-dependent and MIG1-independent regulation of GAL gene expression in Saccharomyces cerevisiae: role of IMP2p 63
Perceived parenting behaviour in the childhood of cocaine users: relationship with genotype and personality traits 62
RAG1 and RAG2: nuclear genes involved in the dependence/independence on mitochondrial respiratory function for growth on sugars 62
Carboxylic acids permeases in yeast: two genes in Kluyveromyces lactis.” 62
A combination of two novel VARS2 variants causes a mitochondrial disorder associated with failure to thrive and pulmonary hypertension 61
Respiration-dependent utilization of sugars in yeast: a determinant role of sugar transporter 61
Mitmed: a multicenter consortium for the identification and characterization of nuclear genes responsisble for human mitochondrial disorders 61
Mutations in the mitochondrial tryptophanyl-tRNA synthetase cause growth retardation and progressive leukoencephalopathy 61
Saccharomyces cerevisiae as a system to discover beneficial molecules for mitochondrial diseases 61
Association between low activity serotonin transporter genotype and heroin dependence: behavioral and personality correlates 60
MUTATIONS IN THE GENES QRSL1, GATB, AND GATC ENCODING THE SUBUNITS OF GLUTAMYL-TRNA(GLN) AMIDOTRANSFERASE CAUSE A MITOCHONDRIAL DISORDER WITH LETHAL INFANTILE CARDIOMYOPATHY 60
Analisi preliminare degli effetti genetici della 2-cloro-10 (3dimetilaminopropil)-fenotiazina 59
Genetic improvement of recombinant protein production in Kluyveromyces lactis 58
"Miglioramento genetico di Kluyveromyces lactis per la produzione di proteine eterologhe 58
The Power of Yeast in Modelling Human Nuclear Mutations Associated with Mitochondrial Diseases 57
Galactose transport in Kluyveromyces lactis: a genomic approach 57
Sym1, the yeast ortholog of the MPV17 human disease protein, is a stress-induced bioenergetic and morphogenetic mitochondrial modulator 57
Identificazione dei bersagli della proteina Imp2p in Saccharomyces cerevisiae 56
HOMOVANILLIC ACID (HVA) PLASMA LEVELS INVERSELY CORRELATE WITH ATTENTION DEFICIT-HYPERACTIVITY AND CHILDHOOD NEGLECT MEASURES IN ADDICTED PATIENTS. 56
The role of the nuclear gene «Mitochondrial Mutability Control» (MMC1) in the process of mutability of the mitochondrial genome by different mutagens in Saccharomyces cerevisiae 56
Association between gene variants and response to buprenorphine maintenance treatment. 56
Galactose transport in Kluyveromyces lactis: major role of the glucose permease Hgt1 55
FOG1 and FOG2 genes, required for the transcriptional activation of glucose-repressible genes of Kluyveromyces lactis are homologous to GAL83 and SNF1 of Saccharomyces cerevisiae 55
The Saccharomyces cerevisiae yeast as a model system to study the human mitochondrial DNA depletion syndromes (MDDS) 55
Cannabinoids abuse: evaluation of genetic vulnerability 55
Mutations in AAC2, equivalent to human adPEO-associated ANT1 mutations, lead to defective oxidative phosphorylation in Saccharomyces cerevisiae and affect mitochondrial DNA stability 54
Infantile Encephalopathy and Defective Mitochondrial DNA Translation in Patients with Mutations of Mitochondrial Elongation Factors EFG1 and EFTu. 54
Il lievito come modello per lo studio di patologie mitocondriali umane 54
Elementi regolativi implicati nel processo di repressione/derepressione da glucosio in Kluyveromyces lactis: differenze rispetto a Saccharomyces cerevisiae 54
Genetic improvement of the yeast Kluyveromyces lactis for biotechnological purposes 54
Effetto del metabolismo fermentativo/ ossidativo e della repressione da glucosio nella produzione di proteine eterologhe in Kluyveromyces lactis 54
Genetics and addiction 54
Sym1, the yeast ortholog of the MPV17 human disease protein, is a stress-induced bioenergetic and morphogenetic mitochondrial modulator 54
The power of yeast in modeling human mutations: mitochondrial aminoacyl tRNA synthetases and mitochondrial tRNA modifiers 54
Three target genes for the transcriptional activator Cat8p of Kluyveromyces lactis: acetyl coenzyme A synthetase genes KlACS1 and KlACS2 and lactate permease gene KlJEN1 54
Gene variants and educational attainment in cannabis use: mediating role of DNA methylation 54
KlJEN1 and KlJEN2: in Kluyveromyces lactis codificano per permesi di acidi di carbossilici 52
Galactose transport in Kluyveromyces lactis 52
ISOLATION AND CHARACTERIZATION OF CARBON CATABOLITE REPRESSION MUTANTS IN SACCHAROMYCES CEREVISIAE. 52
KNQ1a Kluyveromyces lactis gene encoding a transmembrane protein involved in iron homeostasis. 52
A family-based study to identify genetic biomarkers of fibromyalgia: Consideration of patients’ subgroups 52
GERMINATION OF S. CEREVISIAE ASCOSPORES WITHOUT TREHALOSE MOBILIZATION AS REVEALED BY IN VIVO 13C-NMR” 51
Saccharomyces cerevisiae genes release galactose and raffinose utilization from respiration control in Kluyveromyces lactis 51
Psycobiological responses to unpleasant emotions in cannabis users 51
Research of potentially therapeutic molecules for Hepatocerebral Mitochondrial DNA Depletion Syndrome caused by mutations in the MPV17 gene 51
Galactose transport in Kluyveromyces lactis: a genomic approach 50
Saccharomyces cerevisiae genes release galactose and raffinose utilization from respiration in Kluyveromyces lactis 50
MTO1 mutations are associated with hypertrophic cardiomyopathy and lactic acidosis and cause respiratory chain deficiency in humans and yeast 50
Genes release galactose and raffinose utilization from mitochondrial control in Kluyveromyces lactis 49
Totale 6.541
Categoria #
all - tutte 25.453
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.453


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019184 0 0 0 0 0 0 0 0 0 5 164 15
2019/20201.804 290 267 110 37 137 217 208 52 183 164 38 101
2020/2021952 7 99 114 21 121 24 111 24 216 45 139 31
2021/2022727 23 11 6 65 25 17 87 108 28 64 50 243
2022/20232.661 276 232 159 199 238 306 36 181 888 21 99 26
2023/2024749 58 102 36 38 90 222 60 114 15 14 0 0
Totale 8.321